BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26419914)

  • 1. Approximation of head and neck cancer volumes in contrast enhanced CT.
    Dejaco D; Url C; Schartinger VH; Haug AK; Fischer N; Riedl D; Posch A; Riechelmann H; Widmann G
    Cancer Imaging; 2015 Sep; 15():16. PubMed ID: 26419914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific growth rates calculated from CTs in patients with head and neck squamous cell carcinoma: a retrospective study performed in Austria.
    Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
    BMJ Open; 2019 Feb; 9(2):e025359. PubMed ID: 30782931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different approaches to volume assessment of lymph nodes in computer tomography scans of head and neck squamous cell carcinoma in comparison with a real gold standard.
    Mueller S; Wichmann G; Dornheim L; Roessling I; Bertolini J; Preim B; Dietz A; Boehm A
    ANZ J Surg; 2012 Oct; 82(10):737-41. PubMed ID: 22957887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Computerized Tomography density patterns of lymph nodes with treatment results and outcome in head and neck cancer patients treated by 2 different chemoradiotherapy schedules.
    Jaju S; Gupta SK; Pandey S; Singh V
    J Cancer Res Ther; 2014; 10(2):284-93. PubMed ID: 25022379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
    Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open source deformable image registration system for treatment planning and recurrence CT scans : Validation in the head and neck region.
    Zukauskaite R; Brink C; Hansen CR; Bertelsen A; Johansen J; Grau C; Eriksen JG
    Strahlenther Onkol; 2016 Aug; 192(8):545-51. PubMed ID: 27323754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.
    Clavel S; Charron MP; Bélair M; Delouya G; Fortin B; Després P; Soulières D; Filion E; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):567-73. PubMed ID: 21310545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
    Bollineni VR; Koole MJ; Pruim J; Brouwer CL; Wiegman EM; Groen HJ; Vlasman R; Halmos GB; Oosting SF; Langendijk JA; Widder J; Steenbakkers RJ
    Radiother Oncol; 2014 Nov; 113(2):198-203. PubMed ID: 25434768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
    Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
    Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
    Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
    Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?
    Mishra S; Hammond A; Read N; Venkatesan V; Winquist E; Nichols A; Warner A; Palma D
    J Med Imaging Radiat Oncol; 2013 Oct; 57(5):603-9. PubMed ID: 24119277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
    Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
    J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological detection of extracapsular spread in head and neck squamous cell carcinoma (HNSCC) cervical metastases.
    Url C; Schartinger VH; Riechelmann H; Glückert R; Maier H; Trumpp M; Widmann G
    Eur J Radiol; 2013 Oct; 82(10):1783-7. PubMed ID: 23751931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image guided volumetric response during chemoradiotherapy for head and neck squamous cell carcinoma as a predictor of disease outcomes.
    Davuluri R; Krase JM; Cui H; Goyal UD; Cheung MK; Hsu CC; Yi SK
    Am J Otolaryngol; 2016; 37(4):304-10. PubMed ID: 27105977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
    Fayad H; Le Pogam A; Lamare F; Fernandez P; Pradier O; Valette G; Visvikis D; Cheze Le Rest C
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):319-28. PubMed ID: 25265252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.